To create the list, GoodRx excluded drugs that are administered by a healthcare provider and obtained typical fill quantities using drug manufacturer websites to compare the monthly price of these drugs. Using the official manufacturer list price, GoodRx calculated the one-month supply of a typical fill quantity.
GoodRx is an online drug pricing comparison platform.
The 20 most expensive drugs with their monthly list price:
1. Actimmune — $52,322 (Horizon Pharma)
2. Myalept — $46,329 (Aegerion Pharmaceuticals)
3. Daraprim — $45,000 (Vyera Pharmaceuticals)
4. Cinryze — $44,141 (Shire)
5. Takhzyro — $44,140 (Shire)
6. Chenodal — $42,570 (Retrophin)
7. Juxtapid — $40,671 (Aegerion Pharmaceuticals)
8. H.P. Acthar — $38,892 (Mallinckrodt Pharmaceuticals)
9. Tegsedi — $34,600 (Akcea Therapeutics)
10. Ravicti — $33,572 (Horizon Pharma)
11. Vitrakvi — $32,800 (Bayer and Loxo Oncology)
12. Firazyr — $32,468 (Shire)
13. Cuprimine — $31,426 (Valeant Pharmaceuticals)
14. Sovaldi — $28,000 (Gilead)
15. Viekira Pak — $27,773 (AbbVie)
16. Viekira XR — $27,773 (AbbVie)
17. Orfadin — $27,247 (Apotek Produktion and Laboratorier AB)
18. Tibsovo — $26,115 (Agios Pharmaceuticals)
19. Cerdelga — $26,000 (Sanofi Genzyme)
20. Remodulin — $25,466 (United Therapeutics)
More articles on pharmacy:
10 hospitals seeking pharmacy leadership
Patent protection clause is latest stumbling block for revised NAFTA
Dr. Reddy’s legal win expected to lower cost of opioid addiction treatment
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
